Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors
about
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsA global approach to HIV-1 vaccine developmentAdenoviral vectors as novel vaccines for influenza.HIV-1 vaccines: challenges and new perspectivesLongitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.Novel directions in HIV-1 vaccines revealed from clinical trialsNonreplicating vectors in HIV vaccines.Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens.Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectorsSterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopesLate endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity.Novel vaccine vectors for HIV-1.Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humansHIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunityHeterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells.A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria VaccineComparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation.Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization.Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function.Adenovirus vector-induced CD8⁺ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi InfectionInfluence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.Justification for the inclusion of Gag in HIV vaccine candidates.New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses.A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells.Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in MiceClinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.Progress in the development of an adenovirus 26 vector platform for HIV vaccines.Novel Concepts for HIV Vaccine Vector Design.Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo.Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.Advances in HIV-1 Vaccine Development.Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection.
P2860
Q26776553-630CBAFC-D4C6-423E-BCA2-F50EAAEE1D08Q27024614-A297A9BF-106A-4366-B335-D443C25F94ACQ30370445-B076C344-B01E-44F4-87FD-69448D432B24Q33577972-3F77265B-E805-4C0E-9B42-B50ACD1C94E2Q33630150-6AA5575D-9101-4D35-85C4-B5E7853A3C68Q33645528-010A8E1D-94E4-4601-A072-D35999B4EA5BQ33693891-EB0D8CD7-3AFA-4301-99AA-05C7489CCFAAQ33887812-8FE299C3-568C-47EE-B5EE-B500E5A52036Q34057708-70BF25C9-003D-4A47-937A-D3BE940EF5CAQ34165879-B3798EE7-1742-491E-AFEA-7E759906C7A8Q34262192-D96D6EE6-DDAF-4EAC-A8B2-EDA4F2BC3F2AQ34541191-1BFB2EA9-4122-424A-8B3C-9B3EBF712557Q35055188-9EB73520-ACE5-4208-87E6-D56940BD0DF1Q35108680-A8A9BB10-699B-49BC-8E60-D0C94934A57AQ35344875-5B6DC885-F56E-4BA6-BE85-FC59E1445D5DQ35593139-64801BCA-67AB-4BC4-A5EE-7CF3A964540AQ35861968-0644DD6B-6B05-4CAF-8AE5-9961C4258F4AQ36003208-1AEF1E2B-E431-44FD-BDBE-8B10083B664CQ36559772-A0116E52-0B56-43AD-B4FD-458471B02D1FQ36827164-0232EF5D-B181-425A-AE0F-648281E36AA1Q37287424-367BE314-E628-42A2-BEC1-C169F277D302Q37661779-7EC2FA32-7183-4BAD-97A3-A5AF12DE51EFQ37719124-464827F8-CEB0-4BA2-80FF-5C4681CDEB49Q38186768-40ADCA7C-620D-414C-A5AD-0EF291FF5CF2Q38662319-EC07A923-914A-46A6-AEF2-A54846AD7A78Q38748193-8C952FB2-1ACB-47A6-A629-F767077BC0B1Q38789279-62C57859-7E75-4B44-8EC2-3FFF224632ECQ39441716-38B20F02-AACC-41AF-ABDE-1C3D801A680CQ40005891-CA56BCFA-7972-45C1-B5A5-9E51670B5DD5Q40210139-47056206-841C-4D4A-85A5-A092B44E6DDDQ40291652-1D6DCE97-84AE-48CF-9368-438C4F7D291CQ40399897-393464FC-7EB0-44C2-8D11-63373F8D7E31Q42003390-B28B40C6-9BA4-4FDE-89A0-CAD92A4338E3Q45865650-2D74C51D-E365-438E-91C5-13093A993269Q47112156-FDEB75CC-7C93-46A5-852B-E1629850B2B6Q47549105-CFEC7704-F75F-4481-B69C-1BC6DFA3D234Q47558367-40D6A315-9CCC-4A14-8689-CEE3F2E41084Q52586088-4F4596DB-8930-483B-B7A1-9339B3BB481BQ52609661-705DA264-F2D2-4FC4-BEC2-FD5C9C028529Q52668670-76F7015D-885C-4608-A9BA-641401ECD0AD
P2860
Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Alternative serotype adenoviru ...... pacity compared to Ad5 vectors
@ast
Alternative serotype adenoviru ...... pacity compared to Ad5 vectors
@en
type
label
Alternative serotype adenoviru ...... pacity compared to Ad5 vectors
@ast
Alternative serotype adenoviru ...... pacity compared to Ad5 vectors
@en
prefLabel
Alternative serotype adenoviru ...... pacity compared to Ad5 vectors
@ast
Alternative serotype adenoviru ...... pacity compared to Ad5 vectors
@en
P2093
P2860
P356
P1433
P1476
Alternative serotype adenoviru ...... pacity compared to Ad5 vectors
@en
P2093
Anna McNally
Erica N Borducchi
Mark J Iampietro
Nicholas M Provine
Pablo Penaloza-MacMaster
P2860
P304
P356
10.1128/JVI.02058-12
P407
P577
2012-11-14T00:00:00Z